Kiniksa Pharmaceuticals International (KNSA) Net Shares Issued and Repurchased (2017 - 2026)

Kiniksa Pharmaceuticals International (KNSA) has reported Net Shares Issued and Repurchased for 10 consecutive years, with $102260.0 the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Net Shares Issued and Repurchased fell 22.04% year-over-year to $102260.0; the trailing twelve-month figure through Mar 2026 stood at $102260.0 (down 22.04% YoY), and the FY2025 full-year result was $2.1 million, changed N/A from the prior year.
• Net Shares Issued and Repurchased slipped to $102260.0 in Q1 2026 per KNSA's latest filing, from $2.1 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $2.9 million in Q4 2022 and bottomed at $90973.0 in Q1 2023.
• Historically, Net Shares Issued and Repurchased has averaged $1.0 million across 5 years, with a median of $313753.5 in 2022.
• The sharpest annual moves came in 2023 and 2024: Net Shares Issued and Repurchased tumbled 81.67% in 2023, then surged 34.13% in 2024.
• Over 5 years, Net Shares Issued and Repurchased stood at $2.9 million in 2022, then dropped by 27.16% to $2.1 million in 2023, then tumbled by 94.28% to $122026.0 in 2024, then soared by 1591.35% to $2.1 million in 2025, then tumbled by 95.05% to $102260.0 in 2026.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $102260.0, $2.1 million, and $131173.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.